Literature DB >> 28642347

Counteracting dysfunction of regulatory T cells in organ transplantation.

Cees van Kooten1.   

Abstract

Mesh：

Year:  2017        PMID： 28642347      PMCID： PMC5502658          DOI： 10.1073/pnas.1708493114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  14 in total

Review 1.  Regulatory immune cells in transplantation.

Authors:  Kathryn J Wood; Andrew Bushell; Joanna Hester
Journal:  Nat Rev Immunol       Date:  2012-05-25       Impact factor: 53.106

Review 2.  Hurdles in therapy with regulatory T cells.

Authors:  Piotr Trzonkowski; Rosa Bacchetta; Manuela Battaglia; David Berglund; Hermann Richard Bohnenkamp; Anja ten Brinke; Andrew Bushell; Nathalie Cools; Edward K Geissler; Silvia Gregori; S Marieke van Ham; Catharien Hilkens; James A Hutchinson; Giovanna Lombardi; J Alejandro Madrigal; Natalia Marek-Trzonkowska; Eva M Martinez-Caceres; Maria Grazia Roncarolo; Silvia Sanchez-Ramon; Aurore Saudemont; Birgit Sawitzki
Journal:  Sci Transl Med       Date:  2015-09-09       Impact factor: 17.956

Review 3.  Regulatory T cells and immune tolerance.

Authors:  Shimon Sakaguchi; Tomoyuki Yamaguchi; Takashi Nomura; Masahiro Ono
Journal:  Cell       Date:  2008-05-30       Impact factor: 41.582

4.  IL-2 therapy restores regulatory T-cell dysfunction induced by calcineurin inhibitors.

Authors:  Gavin Whitehouse; Elizabeth Gray; Sotiris Mastoridis; Elliot Merritt; Elisavet Kodela; Jennie H M Yang; Richard Danger; Marta Mairal; Sofia Christakoudi; Juan J Lozano; Iain C Macdougall; Timothy I M Tree; Alberto Sanchez-Fueyo; Marc Martinez-Llordella
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-05       Impact factor: 11.205

5.  Low-dose IL-2 selectively activates subsets of CD4+ Tregs and NK cells.

Authors:  Masahiro Hirakawa; Tiago R Matos; Hongye Liu; John Koreth; Haesook T Kim; Nicole E Paul; Kazuyuki Murase; Jennifer Whangbo; Ana C Alho; Sarah Nikiforow; Corey Cutler; Vincent T Ho; Philippe Armand; Edwin P Alyea; Joseph H Antin; Bruce R Blazar; Joao F Lacerda; Robert J Soiffer; Jerome Ritz
Journal:  JCI Insight       Date:  2016-11-03

6.  Interleukin-2 and regulatory T cells in graft-versus-host disease.

Authors:  John Koreth; Ken-ichi Matsuoka; Haesook T Kim; Sean M McDonough; Bhavjot Bindra; Edwin P Alyea; Philippe Armand; Corey Cutler; Vincent T Ho; Nathaniel S Treister; Don C Bienfang; Sashank Prasad; Dmitrios Tzachanis; Robin M Joyce; David E Avigan; Joseph H Antin; Jerome Ritz; Robert J Soiffer
Journal:  N Engl J Med       Date:  2011-12-01       Impact factor: 91.245

7.  Selective IL-2 responsiveness of regulatory T cells through multiple intrinsic mechanisms supports the use of low-dose IL-2 therapy in type 1 diabetes.

Authors:  Aixin Yu; Isaac Snowhite; Francesco Vendrame; Michelle Rosenzwajg; David Klatzmann; Alberto Pugliese; Thomas R Malek
Journal:  Diabetes       Date:  2015-01-09       Impact factor: 9.461

8.  Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I study.

Authors:  Marlies E J Reinders; Johan W de Fijter; Helene Roelofs; Ingeborg M Bajema; Dorottya K de Vries; Alexander F Schaapherder; Frans H J Claas; Paula P M C van Miert; Dave L Roelen; Cees van Kooten; Willem E Fibbe; Ton J Rabelink
Journal:  Stem Cells Transl Med       Date:  2013-01-24       Impact factor: 6.940

9.  Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor.

Authors:  Makoto Miyara; Yumiko Yoshioka; Akihiko Kitoh; Tomoko Shima; Kajsa Wing; Akira Niwa; Christophe Parizot; Cécile Taflin; Toshio Heike; Dominique Valeyre; Alexis Mathian; Tatsutoshi Nakahata; Tomoyuki Yamaguchi; Takashi Nomura; Masahiro Ono; Zahir Amoura; Guy Gorochov; Shimon Sakaguchi
Journal:  Immunity       Date:  2009-05-21       Impact factor: 31.745

10.  Rapamycin/IL-2 combination therapy in patients with type 1 diabetes augments Tregs yet transiently impairs β-cell function.

Authors:  S Alice Long; Mary Rieck; Srinath Sanda; Jennifer B Bollyky; Peter L Samuels; Robin Goland; Andrew Ahmann; Alex Rabinovitch; Sudeepta Aggarwal; Deborah Phippard; Laurence A Turka; Mario R Ehlers; Peter J Bianchine; Karen D Boyle; Steven A Adah; Jeffrey A Bluestone; Jane H Buckner; Carla J Greenbaum
Journal:  Diabetes       Date:  2012-06-20       Impact factor: 9.461
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.